Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

42.73
+0.69001.64%
Post-market: 42.62-0.1145-0.27%19:59 EDT
Volume:13.04M
Turnover:553.53M
Market Cap:61.93B
PE:17.31
High:42.83
Open:42.12
Low:41.97
Close:42.04
52wk High:105.65
52wk Low:41.39
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.78
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.48
PE(LYR):22.03

Loading ...

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
13 hours ago

MedTech Growth Concerns Likely to Overshadow Q3 Results, Leerink Says

Reuters
·
Yesterday

Boston Scientific Corp : Leerink Partners Cuts Target Price to $55 from $60

THOMSON REUTERS
·
Yesterday

Evercore ISI Adjusts Price Target on Boston Scientific to $52 From $65

MT Newswires Live
·
Oct 07

Boston Scientific Appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer

THOMSON REUTERS
·
Oct 07

Boston Scientific Corp - to Establish Three Reportable Segments Effective Jan. 1, 2027

THOMSON REUTERS
·
Oct 07

Boston Scientific Names Joseph Fitzgerald as COO, Effective Jan. 1, 2027

Reuters
·
Oct 07

Boston Scientific Corp. : Barclays Initiates Coverage with Equal-Weight Rating and Target Price $48

THOMSON REUTERS
·
Oct 07

Citigroup Adjusts Price Target on Boston Scientific to $48 From $50, Keeps Neutral Rating

MT Newswires Live
·
Oct 05

Citi cuts Boston Scientific target, opens ‘downside 90-day catalyst watch’

TIPRANKS
·
Oct 05

US Research Roundup-Danaher Corporation, Illumina, Reliance

Reuters
·
Oct 05

Boston Scientific Corp : Bernstein Cuts Target Price to $54 from $60

THOMSON REUTERS
·
Oct 05

Boston Scientific (BSX) Receives a Buy from RBC Capital

TIPRANKS
·
Oct 03

Elutia Receives $8 Million Payment from Boston Scientific; Company NOW Fully Funded into 2029

THOMSON REUTERS
·
Oct 02

Elutia: Continues to Expect Favorable FDA Clearance Decision for NXT-41X in H1 2027

THOMSON REUTERS
·
Oct 02

Press Release: Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Dow Jones
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Artiva Biotherapeutics, Inc. (ARTV)

TIPRANKS
·
Oct 02

US FDA - Classifies Imager Ii Angiographic Catheter Recall as Class I Due to Injury Risk

THOMSON REUTERS
·
Sep 26

US FDA - Boston Scientific Reports Two Serious Injuries, no Deaths from Imager Ii Catheter Defect

THOMSON REUTERS
·
Sep 26

Boston Scientific Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 26